HUTCHMED (China) (HCM) Receivables - Net (2014 - 2025)
HUTCHMED (China)'s (HCM) quarterly Receivables - Net came in at $16.3 million in Q4 2025, down 18.54% year-on-year from $20.0 million in Q4 2024, and down 88.91% on a QoQ basis from $147.0 million in Q2 2025.
HUTCHMED (China) (HCM) Receivables - Net (2014 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 12 years of Receivables - Net data on file, last reported at $16.3 million in Q4 2025.
- On a quarterly basis, Receivables - Net fell 18.54% year-over-year to $16.3 million in Q4 2025; TTM through Dec 2025 was $16.3 million, a 18.54% decrease from a year earlier, with the FY2025 full-year figure at -$4.6 million, down 42.35% from the prior year.
- Receivables - Net for Q4 2025 stood at $16.3 million, down from $147.0 million in the prior quarter.
- Over the last five years, Receivables - Net for HCM reached as high as $15.0 billion in Q4 2023 and fell as low as $10.7 million in Q4 2021.
- Historically, Receivables - Net has averaged $1.4 billion across 5 years, with a median of $58.0 million in 2021.
- Across the five-year window, Receivables - Net surged 119327.04% in 2023 and slumped 99.87% in 2024, its largest moves.
- Year by year, Receivables - Net stood at $10.7 million in 2021, then climbed by 16.75% to $12.5 million in 2022, then jumped by 119327.04% to $15.0 billion in 2023, then slumped by 99.87% to $20.0 million in 2024, then declined by 18.54% to $16.3 million in 2025.
- Per Business Quant data, the three most recent Receivables - Net figures were $16.3 million in Q4 2025, $147.0 million in Q2 2025, and $20.0 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.30 Mn |
| Dec 31, 2025 | 16.30 Mn |
| Jun 30, 2025 | 146.97 Mn |
| Jun 30, 2025 | 146.97 Mn |
| Dec 31, 2024 | 20.01 Mn |
| Dec 31, 2024 | 20.01 Mn |
| Jun 30, 2024 | 156.92 Mn |
| Jun 30, 2024 | 156.92 Mn |
| Dec 31, 2023 | 14.96 Bn |
| Dec 31, 2023 | 14.96 Bn |
| Jun 30, 2023 | 129.20 Mn |
| Jun 30, 2023 | 129.20 Mn |
| Dec 31, 2022 | 12.53 Mn |
| Dec 31, 2022 | 12.53 Mn |
| Jun 30, 2022 | 77.08 Mn |
| Jun 30, 2022 | 77.08 Mn |
| Dec 31, 2021 | 10.73 Mn |
| Dec 31, 2021 | 10.73 Mn |
| Jun 30, 2021 | 57.95 Mn |
| Jun 30, 2021 | 57.95 Mn |